A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

NCT00836940 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: GRC 8200

Sponsor

Glenmark Pharmaceuticals Europe Ltd. (R&D)